Author

Oliver Keil

Pantherna Therapeutics GmbH;ORCID 0009-0005-3235-1782Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:multiome· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Ansgar Santel· 1 shared Charlotte Maeve DunneiD· 1 shared Daniel TonderaiD· 1 shared Joerg Kaufmann· 1 shared Katrin RadloffiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Ansgar Santel

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintNov 12, 2026

mRNA/LNP-mediated expression of a ligand-independent Tie2 pathway activator, COMP-Tie2*, enables sustained endothelial stabilization

Katrin Radloff, Charlotte Maeve Dunne, Oliver Keil…·Daniel Tondera

This paper develops a method to sustain Tie2 activation using engineered mRNA, showing improved endothelial stabilization compared to traditional ligands.

DOI 10.64898/2026.11.10.765541

humanmultiome

𝕏 PostBluesky